Go back

Go to
André-Michel Ballester

“ARCHIMED’s approach goes beyond conventional investment in the healthcare industry from the outside looking in. We are deeply embedded within the healthcare community. Our dedication extends far beyond investment, as we proactively participate in trade associations and foster innovation in the companies we support. Not simply stakeholders, we are true business partners, and it’s this spirit of collaboration that distinguishes us.”


Managing Partner

Sector: MedTech


André-Michel Ballester is a Managing Partner. He is leading the ARCHIMED MedTech Sector. André-Michel has a long-standing relationship with other ARCHIMED Partners.

André-Michel joined ARCHIMED in 2017 as a Strategic Partner. Prior to this, he was working with ARCHIMED as a MedTalent®. He became a Partner in 2018.

He has accrued over 30 years of experience in the healthcare sector, through CEO and non-executive Director positions in European and US MedTech companies, such as LivaNova (formed through the merger of Cyberonics and Sorin Group), Edwards Lifesciences and Baxter.

Over the course of his career, André-Michel has overseen the integration of more than 15 acquisitions and has successfully led the IPOs of three companies as either CEO or Board Member.

André-Michel currently serves as a non-executive Director in Italian manufacturer of cardiology devices, Cardioline, French testing service provider, CARSO, US based Contract Research Organization (CRO), NAMSA, US based medical device solutions provider, Natus, and as a Chairman of the Board (non-executive) of Spanish manufacturer of APIs, SUANFARMA.

André-Michel is a member of the healthcare taskforce of the Institut Montaigne, a leading independent think tank, and founded the professional association “MedTech in France”.


Natus Medical Incorporated